Transdermal Drug Delivery System

Transdermal drug delivery systems (TDDS) have gained widespread acceptance as a preferred route for achieving localized drug effects. TDDS are particularly beneficial for drugs that undergo hepatic first-pass metabolism and are vulnerable to degradation in the gastrointestinal tract. Recent advances in TDDS technology have enabled precise drug delivery to the site of action without breaching the skin’s barrier. Transdermal administration has become increasingly popular, and ongoing research is exploring the incorporation of a broader range of drugs into this delivery system. Future developments in TDDS will likely emphasize improved control over therapeutic regimens and an expansion of the available drugs. In a transdermal drug delivery system, a medicated patch is affixed to the skin to administer a specific drug dose through the skin’s pores, allowing the drug to enter the systemic circulation. This is often advantageous for targeting injured areas of the body. One of the key advantages of transdermal drug delivery over other routes, such as oral, intravenous, or intramuscular, is its ability to provide controlled and sustained release of the active pharmaceutical ingredient. Transdermal drug delivery is a crucial component of modern drug delivery systems, offering a practical way to administer medications in the form of patches that, when applied to the skin, effectively deliver the drug to the patient.